KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $702,399 | +334.9% | 3,239 | +294.0% | 0.01% | +400.0% |
| Q4 2022 | $161,523 | -97.7% | 822 | -97.4% | 0.00% | -97.4% |
| Q3 2022 | $7,003,000 | +566.3% | 31,134 | +274.7% | 0.04% | +550.0% |
| Q2 2022 | $1,051,000 | -47.8% | 8,310 | -47.6% | 0.01% | -64.7% |
| Q1 2022 | $2,012,000 | +31.2% | 15,872 | +35.7% | 0.02% | +13.3% |
| Q4 2021 | $1,533,000 | +55.5% | 11,699 | +45.1% | 0.02% | +25.0% |
| Q3 2021 | $986,000 | +381.0% | 8,061 | +347.3% | 0.01% | +500.0% |
| Q2 2021 | $205,000 | -24.1% | 1,802 | -19.7% | 0.00% | -33.3% |
| Q1 2021 | $270,000 | +12.0% | 2,245 | -27.9% | 0.00% | -25.0% |
| Q3 2020 | $241,000 | +17.0% | 3,112 | +68.8% | 0.00% | 0.0% |
| Q2 2020 | $206,000 | -29.0% | 1,844 | -52.0% | 0.00% | -20.0% |
| Q4 2019 | $290,000 | +211.8% | 3,845 | -32.6% | 0.01% | +150.0% |
| Q3 2019 | $93,000 | – | 5,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |